Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04952597
Title Study of Ociperlimab Plus Tislelizumab Plus Chemoradiotherapy in Participants With Untreated Limited-Stage Small Cell Lung Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors BeiGene
Indications

lung small cell carcinoma

Therapies

Tislelizumab

BGBA1217 + Tislelizumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.